AR065816A1 - Regimen anticonceptivo oral - Google Patents
Regimen anticonceptivo oralInfo
- Publication number
- AR065816A1 AR065816A1 ARP080101187A ARP080101187A AR065816A1 AR 065816 A1 AR065816 A1 AR 065816A1 AR P080101187 A ARP080101187 A AR P080101187A AR P080101187 A ARP080101187 A AR P080101187A AR 065816 A1 AR065816 A1 AR 065816A1
- Authority
- AR
- Argentina
- Prior art keywords
- oral contraceptive
- estradiol
- beta
- oral
- days
- Prior art date
Links
- 229940127234 oral contraceptive Drugs 0.000 title abstract 5
- 239000003539 oral contraceptive agent Substances 0.000 title abstract 5
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 8
- 229960005309 estradiol Drugs 0.000 abstract 4
- 229960004190 nomegestrol acetate Drugs 0.000 abstract 4
- IIVBFTNIGYRNQY-YQLZSBIMSA-N nomegestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 IIVBFTNIGYRNQY-YQLZSBIMSA-N 0.000 abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 230000003054 hormonal effect Effects 0.000 abstract 2
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 229940068196 placebo Drugs 0.000 abstract 1
- 239000000902 placebo Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Un método monofásico para lograr la anticoncepcion en una mujer, que consiste en administrar oralmente a la mujer una composicion que comprende 1,5 mg de 17-beta--estradiol y 2,5 mg de acetato de nomegestrol durante 24 días, seguido de un períodolibre de hormonas de 4 días. Reivindicacion 11: Una composicion hormonal oral que comprende 1,5 mg de 17-beta-estradiol y 2,5 mg de acetato de nomegestrol para utilizar como un producto anticonceptivo oral para ser administrado durante 24 díasseguido de un período de 4 días libre de hormona. Reivindicacion 12: El uso de una composicion hormonal oral que comprende 1,5 mg de 17-beta-estradiol y 2,5 mg de acetato de nomegestrol para la preparacion de un producto anticonceptivo oral paraser administrado durante 24 días seguido de un período de 4 días libre de hormona. Reivindicacion 13: Un producto anticonceptivo oral que comprende 24 unidades de dosis, cada una de las cuales comprende 1,5 mg de 17-beta-estradiol y 2,5 mg deacetato de nomegestrol. Reivindicacion 14: El producto anticonceptivo oral de acuerdo con la reivindicacion 13, que además comprende 4 unidades de dosis de placebo.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92032607P | 2007-03-26 | 2007-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR065816A1 true AR065816A1 (es) | 2009-07-01 |
Family
ID=39672648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080101187A AR065816A1 (es) | 2007-03-26 | 2008-03-25 | Regimen anticonceptivo oral |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20080242650A1 (es) |
| AR (1) | AR065816A1 (es) |
| AU (1) | AU2008231744A1 (es) |
| BR (1) | BRPI0809089A2 (es) |
| CA (1) | CA2682049A1 (es) |
| CL (1) | CL2008000866A1 (es) |
| MX (1) | MX2009010320A (es) |
| PE (1) | PE20081895A1 (es) |
| TW (1) | TWI472332B (es) |
| WO (1) | WO2008116873A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001030356A1 (fr) | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation |
| US8741329B2 (en) * | 2007-09-21 | 2014-06-03 | Merck Sharp & Dohme B.V. | Drug delivery system |
| EP2343979B1 (en) | 2008-10-08 | 2020-04-08 | Agile Therapeutics, Inc. | Transdermal delivery |
| US9198876B2 (en) | 2008-10-08 | 2015-12-01 | Agile Therapeutics, Inc. | Contraceptive transdermal delivery of hormones |
| EP2343964A4 (en) | 2008-10-08 | 2012-11-07 | Agile Therapeutics Inc | TRANSDERMAL ADMINISTRATION |
| EP2410859A4 (en) | 2009-03-27 | 2013-03-13 | Agile Therapeutics Inc | TRANSDERMAL ADMINISTRATION |
| US10413504B2 (en) | 2013-12-11 | 2019-09-17 | Merck Sharp & Dohme Corp. | Intravaginal ring drug delivery system |
| EP3079659B1 (en) | 2013-12-11 | 2020-10-28 | Merck Sharp & Dohme B.V. | Drug delivery system for delivery of anti-virals |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826831A (en) * | 1983-08-05 | 1989-05-02 | Pre Jay Holdings Limited | Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens |
| JPS61243059A (ja) * | 1985-04-19 | 1986-10-29 | Konishi Kagaku Kogyo Kk | 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法 |
| US5108995A (en) * | 1987-09-24 | 1992-04-28 | Jencap Research Ltd. | Hormone preparation and method |
| US5674863A (en) * | 1991-10-18 | 1997-10-07 | Genentech, Inc. | Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor |
| US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
| DE4344462C2 (de) * | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| US5552394A (en) * | 1994-07-22 | 1996-09-03 | The Medical College Of Hampton Roads | Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy |
| FR2737411B1 (fr) * | 1995-08-01 | 1997-10-17 | Theramex | Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques |
| US5888543A (en) * | 1996-07-26 | 1999-03-30 | American Home Products Corporation | Oral contraceptives |
| FR2754179B1 (fr) * | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| CA2507509A1 (en) * | 2002-11-25 | 2004-06-10 | Mochida Pharmaceutical Co., Ltd. | Therapeutic agent for respiratory disease containing 4-hydroxypiperidine derivative as active ingredient |
-
2008
- 2008-03-25 US US12/079,335 patent/US20080242650A1/en not_active Abandoned
- 2008-03-25 PE PE2008000538A patent/PE20081895A1/es not_active Application Discontinuation
- 2008-03-25 AR ARP080101187A patent/AR065816A1/es unknown
- 2008-03-26 CL CL200800866A patent/CL2008000866A1/es unknown
- 2008-03-26 BR BRPI0809089-0A patent/BRPI0809089A2/pt not_active IP Right Cessation
- 2008-03-26 WO PCT/EP2008/053546 patent/WO2008116873A1/en not_active Ceased
- 2008-03-26 CA CA002682049A patent/CA2682049A1/en not_active Abandoned
- 2008-03-26 MX MX2009010320A patent/MX2009010320A/es not_active Application Discontinuation
- 2008-03-26 AU AU2008231744A patent/AU2008231744A1/en not_active Abandoned
- 2008-03-26 TW TW97110851A patent/TWI472332B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CL2008000866A1 (es) | 2008-10-03 |
| CA2682049A1 (en) | 2008-10-02 |
| PE20081895A1 (es) | 2009-01-26 |
| TWI472332B (zh) | 2015-02-11 |
| TW200902031A (en) | 2009-01-16 |
| BRPI0809089A2 (pt) | 2014-09-09 |
| MX2009010320A (es) | 2010-01-20 |
| WO2008116873A1 (en) | 2008-10-02 |
| US20080242650A1 (en) | 2008-10-02 |
| AU2008231744A1 (en) | 2008-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR065816A1 (es) | Regimen anticonceptivo oral | |
| EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
| CO6251259A2 (es) | Formulaciones farmaceuticas de estriol en baja dosis | |
| JP2010525050A5 (es) | ||
| CL2016001411A1 (es) | Unidad de dosificación farmacéutica solida de desintegración oral que comprende un componente de estetrol; metodo de preparación; uso para la anticoncepción femenina y en terápia de sustitución hormonal femenina. | |
| ES2916649T1 (es) | Composiciones y usos para el tratamiento de la esclerosis múltiple | |
| MX2008011074A (es) | Metodo anticonceptivo oral multifasico de ciclo prolongado. | |
| JP2013529665A5 (es) | ||
| BRPI0514180A (pt) | composto, composição farmacêutica, uso de um composto, kit farmaceuticamente útil adaptado para administração oral diária, e, métodos de preparação de um composto, e de contracepção em um mamìfero | |
| AR075735A1 (es) | Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso | |
| AU2012293593A8 (en) | Use of estetrol as emergency contraceptive | |
| JP2013516493A5 (es) | ||
| HUP0105173A2 (hu) | Adagolási módszer és készítmény sürgősségi fogamzásgátlásra | |
| JP2009512658A5 (es) | ||
| HRP20192189T1 (hr) | Doziranja i terapijske primjene l-4-klorokinurenina | |
| AR065582A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
| MX2007013137A (es) | Regimen anticonceptivo con dosificacion de estrogeno ampliada. | |
| AR065971A1 (es) | Nuevo regimen de drosperinona/17beta-estradiol, producto farmaceutica combinado y conjunto de elementos (kit) para su aplicacion | |
| JP2011507853A5 (es) | ||
| AR048318A1 (es) | Formulaciones de matriz orales que comprenden licarbazepina | |
| HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
| BR0014952A (pt) | Medicamento contraceptivo e seu modo de preparação | |
| JP2005532336A5 (es) | ||
| NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
| BR112015010650A2 (pt) | composição contendo somente levonorgestrel melhorada para contracepção oral otimizada com conteúdo definido de levonorgestrel, regime de dosagem e preparo farmacêutico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |